Karen Langhart never thought she would outlive her daughter. However, due to insufficient drug testing and inadequate medical warnings, NuvaRing caused blood clots, pulmonary embolisms and heart attacks resulting in her daughter Erika’s death in 2011. Erika was 24.
The only conscionable way for the Langharts to pursue a legal case was to press for a jury trial. This would expose Merck, the maker of NuvaRing, and gain media coverage so women would be aware of the complications and lives would be saved.
The jury trial never happened because the lawyers settled out of court in a class action suit. The lawsuit covered 3,800 women, 83 of them who died. In Karen Langhart’s mind, Merck got away with murder.
In 2014, Merck made an inconceivable $723 million from NuvaRing. Merck claims that NuvaRing has an “acceptable risk factor”. For the Langharts, nothing is “acceptable” about Erika’s death, other deaths or life altering injuries caused by NuvaRing.
To expose the truth of the risky NuvaRing and raise awareness of its complications, the Langharts have created a foundation in memory of their daughter. The mission of InformedChoiceForAmErika.com is to save lives by sharing honest information.
Too many young women have been struck down in the prime of life by the lethal effects of NuvaRing.
If you or someone you know has been harmed by NuvaRing, please call our medical liability attorneys at 1-800-721-2519 or send an email. There is no cost or commitment on your part for an initial case evaluation.References: NuvaRing, Pharmaceutical litigation